Humana (HUM) EBIT (2009 - 2026)

Humana has reported EBIT for 18 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 12.91% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $2.4 billion (down 26.83% YoY), and the FY2025 full-year result was $2.7 billion, up 5.54% from the prior year.
• EBIT for Q1 2026 stood at $1.8 billion, up from -$808.0 million in the prior quarter.
• The five-year high for EBIT was $2.0 billion in Q1 2025, with the low at -$808.0 million in Q4 2025.
• Average EBIT over 5 years is $872.5 million, with a median of $1.2 billion recorded in 2022.
• Year-over-year, EBIT soared 3651.52% in 2022 and slumped 380.65% in 2023.
• Tracing HUM's EBIT over 5 years: stood at $124.0 million in 2022, then tumbled by 380.65% to -$348.0 million in 2023, then plunged by 56.03% to -$543.0 million in 2024, then tumbled by 48.8% to -$808.0 million in 2025, then soared by 317.08% to $1.8 billion in 2026.
• The last three EBIT figures came in at $1.8 billion (Q1 2026), -$808.0 million (Q4 2025), and $400.0 million (Q3 2025), per Business Quant data.

Peer Comparison